Revvity Overview
- Year Founded
-
1937
- Status
-
Public
- Employees
-
11,000
- Stock Symbol
-
RVTY
- Investments
-
68
- Share Price
-
$111.91
- (As of Friday Closing)
Revvity General Information
Description
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Contact Information
Website
www.revvity.comCorporate Office
- 940 Winter Street
- Waltham, MA 02451
- United States
Corporate Office
- 940 Winter Street
- Waltham, MA 02451
- United States
Revvity Timeline
Revvity Stock Performance
As of 14-Mar-2025, Revvity’s stock price is $111.91. Its current market cap is $13.4B with 120M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $111.91 | $110.32 | $97.31 - $129.50 | $13.4B | 120M | 917K | $2.21 |
Revvity Financials Summary
As of 31-Dec-2024, Revvity has a trailing 12-month revenue of $2.76B.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 15,668,541 | 15,668,541 | 16,073,874 | 21,855,935 |
| Revenue | 2,755,026 | 2,755,026 | 2,750,571 | 3,311,822 |
| EBITDA | 407,714 | 407,714 | 276,358 | 808,603 |
| Net Income | 270,385 | 270,385 | 693,094 | 569,179 |
| Total Assets | 12,392,478 | 12,392,478 | 13,564,665 | 14,129,855 |
| Total Debt | 3,325,805 | 3,325,805 | 4,065,295 | 4,595,461 |
Revvity Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Revvity Comparisons
Industry
Financing
Details
Revvity Competitors (22)
One of Revvity’s 22 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
| Heska | Private Equity-Backed | Loveland, CO | ||||
| GE HealthCare Technologies | Corporation | Chicago, IL | ||||
| Oxford Immunotec | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Sarstedt | Corporation | Numbrecht, Germany |
Revvity Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Revvity Patents
Revvity Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240272122-A1 | Analyzing moisture sensitive/reactive gases | Inactive | 13-Feb-2023 | ||
| US-20240164005-A1 | Induction devices for inductively coupled plasma torches and methods and systems including same | Pending | 16-Nov-2022 | ||
| US-20240094172-A1 | Metal reinforced cryogenic trap for thermal desorber | Pending | 21-Sep-2022 | ||
| US-20240032181-A1 | Generating inductively coupled plasma | Inactive | 21-Jul-2022 | ||
| US-20230366038-A1 | Compositions and methods relating to loop mediated isothermal amplification (lamp) | Pending | 16-May-2022 | C12Q1/689 |
Revvity Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Revvity Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Revvity Investments & Acquisitions (68)
Revvity’s most recent deal was a Merger/Acquisition with SonoVol. The deal was made on 07-Feb-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SonoVol | 07-Feb-2022 | Merger/Acquisition | Diagnostic Equipment | ||
| Virtue DX | 06-Jan-2022 | Early Stage VC | Laboratory Services (Healthcare) | ||
| BioLegend | 17-Sep-2021 | Merger/Acquisition | Biotechnology | ||
| Sirion Biotech | 31-Aug-2021 | Merger/Acquisition | Biotechnology | ||
| Immunodiagnostic Systems Holdings | 12-Jul-2021 | Merger/Acquisition | Diagnostic Equipment |
Revvity ESG
Risk Overview
Risk Rating
Updated October, 04, 2024
15.58 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,946
Rank
Percentile
Pharmaceuticals
Industry
of 847
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 60
Rank
Percentile
Revvity Exits (6)
Revvity’s most recent exit was on 01-Jan-2015 from Fluent Wave. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Fluent Wave | 01-Jan-2015 | Completed |
|
||
| Eurofins NTD | 27-Jul-2006 | Completed |
|
||
| Alara | 29-Oct-2003 | Completed |
|
||
| Alara | 06-Jun-2002 | Completed |
|
||
| Voltarc Technologies | 02-Oct-1997 | Merger/Acquisition | Completed |
Revvity Affiliates
Subsidiaries (14)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SonoVol | Durham, NC | 2012 | |
| ArtusLabs | Durham, NC | 2007 | |
| Horizon Discovery | Cambridge, United Kingdom | 2005 | |
| Sirion Biotech | Grafelfing, Germany | 2005 | |
| Spectra Analysis Instruments | Marlborough, MA | 2004 |
Revvity FAQs
-
When was Revvity founded?
Revvity was founded in 1937.
-
Where is Revvity headquartered?
Revvity is headquartered in Waltham, MA.
-
What is the size of Revvity?
Revvity has 11,000 total employees.
-
What industry is Revvity in?
Revvity’s primary industry is Diagnostic Equipment.
-
Is Revvity a private or public company?
Revvity is a Public company.
-
What is Revvity’s stock symbol?
The ticker symbol for Revvity is RVTY.
-
What is the current stock price of Revvity?
As of 14-Mar-2025 the stock price of Revvity is $111.91.
-
What is the current market cap of Revvity?
The current market capitalization of Revvity is $13.4B.
-
What is Revvity’s current revenue?
The trailing twelve month revenue for Revvity is $2.76B.
-
Who are Revvity’s competitors?
Bio-Rad Laboratories, Heska, GE HealthCare Technologies, Oxford Immunotec, and Sarstedt are some of the 22 competitors of Revvity.
-
What is Revvity’s annual earnings per share (EPS)?
Revvity’s EPS for 12 months was $2.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
